(IPAR) Inter Parfums - Ratings and Ratios
Fragrance, Cosmetics, Skincare, Beauty
Dividends
| Dividend Yield | 4.86% |
| Yield on Cost 5y | 7.71% |
| Yield CAGR 5y | 73.64% |
| Payout Consistency | 92.6% |
| Payout Ratio | 61.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 33.5% |
| Value at Risk 5%th | 54.3% |
| Relative Tail Risk | -1.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.50 |
| Alpha | -52.20 |
| CAGR/Max DD | -0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.611 |
| Beta | 0.802 |
| Beta Downside | 0.811 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.51% |
| Mean DD | 15.73% |
| Median DD | 15.00% |
Description: IPAR Inter Parfums November 07, 2025
Interparfums, Inc. (NASDAQ: IPAR) is a New York-based company that designs, manufactures, markets, and distributes fragrance and related cosmetic products in the United States and internationally.
The business is organized into two geographic segments-European-Based Operations and United States-Based Operations-and leverages a licensed-brand model that includes luxury and mainstream names such as Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Montblanc, Rochas, Van Cleef & Arpels, Abercrombie & Fitch, DKNY, Ferragamo, Guess, Lacoste, and Roberto Cavalli, among others.
Products are sold through a diversified channel mix that comprises department stores, specialty perfumeries, duty-free locations, wholesale distributors, and direct-to-consumer e-commerce platforms.
According to the company’s FY 2023 Form 10-K, net sales were approximately $1.04 billion, with an adjusted EBITDA margin of roughly 13 %, reflecting modest top-line growth (≈ 4 % YoY) driven by expanding e-commerce penetration and new licensing agreements.
Key industry dynamics that affect IPAR include the global luxury fragrance market’s projected CAGR of 5–6 % through 2028, the sensitivity of discretionary spend to consumer confidence and inflation, and the accelerating shift toward online fragrance sales, which now accounts for about 15 % of total volume in the sector.
For a deeper, data-driven valuation of IPAR, consider reviewing the detailed metrics and scenario analyses available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (164.5m TTM) > 0 and > 6% of Revenue (6% = 87.8m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 3.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.00% (prev 43.45%; Δ 3.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 206.3m > Net Income 164.5m (YES >=105%, WARN >=100%) |
| Net Debt (119.5m) to EBITDA (310.4m) ratio: 0.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.1m) change vs 12m ago -0.36% (target <= -2.0% for YES) |
| Gross Margin 64.41% (prev 63.89%; Δ 0.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.14% (prev 95.88%; Δ 0.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 36.38 (EBITDA TTM 310.4m / Interest Expense TTM 7.74m) >= 6 (WARN >= 3) |
Altman Z'' 7.73
| (A) 0.44 = (Total Current Assets 990.7m - Total Current Liabilities 302.8m) / Total Assets 1.56b |
| (B) 0.53 = Retained Earnings (Balance) 827.0m / Total Assets 1.56b |
| (C) 0.18 = EBIT TTM 281.4m / Avg Total Assets 1.52b |
| (D) 1.79 = Book Value of Equity 822.2m / Total Liabilities 460.2m |
| Total Rating: 7.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.40
| 1. Piotroski 7.50pt |
| 2. FCF Yield 5.46% |
| 3. FCF Margin 9.79% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 0.38 |
| 6. ROIC - WACC (= 13.34)% |
| 7. RoE 20.29% |
| 8. Rev. Trend 84.92% |
| 9. EPS Trend 46.31% |
What is the price of IPAR shares?
Over the past week, the price has changed by +0.56%, over one month by -6.62%, over three months by -27.99% and over the past year by -39.33%.
Is IPAR a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IPAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.8 | 26.4% |
| Analysts Target Price | 102.8 | 26.4% |
| ValueRay Target Price | 74.2 | -8.7% |
IPAR Fundamental Data Overview November 25, 2025
P/E Trailing = 15.7135
P/E Forward = 15.3846
P/S = 1.7657
P/B = 2.9665
P/EG = 2.73
Beta = 1.256
Revenue TTM = 1.46b USD
EBIT TTM = 281.4m USD
EBITDA TTM = 310.4m USD
Long Term Debt = 140.0m USD (from longTermDebt, last quarter)
Short Term Debt = 72.5m USD (from shortTermDebt, last quarter)
Debt = 229.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 119.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.63b USD (2.58b + Debt 229.9m - CCE 187.9m)
Interest Coverage Ratio = 36.38 (Ebit TTM 281.4m / Interest Expense TTM 7.74m)
FCF Yield = 5.46% (FCF TTM 143.3m / Enterprise Value 2.63b)
FCF Margin = 9.79% (FCF TTM 143.3m / Revenue TTM 1.46b)
Net Margin = 11.24% (Net Income TTM 164.5m / Revenue TTM 1.46b)
Gross Margin = 64.41% ((Revenue TTM 1.46b - Cost of Revenue TTM 520.9m) / Revenue TTM)
Gross Margin QoQ = 63.51% (prev 66.21%)
Tobins Q-Ratio = 1.68 (Enterprise Value 2.63b / Total Assets 1.56b)
Interest Expense / Debt = 1.00% (Interest Expense 2.31m / Debt 229.9m)
Taxrate = 22.58% (24.3m / 107.6m)
NOPAT = 217.9m (EBIT 281.4m * (1 - 22.58%))
Current Ratio = 3.27 (Total Current Assets 990.7m / Total Current Liabilities 302.8m)
Debt / Equity = 0.26 (Debt 229.9m / totalStockholderEquity, last quarter 870.9m)
Debt / EBITDA = 0.38 (Net Debt 119.5m / EBITDA 310.4m)
Debt / FCF = 0.83 (Net Debt 119.5m / FCF TTM 143.3m)
Total Stockholder Equity = 810.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.51% (Net Income 164.5m / Total Assets 1.56b)
RoE = 20.29% (Net Income TTM 164.5m / Total Stockholder Equity 810.9m)
RoCE = 29.60% (EBIT 281.4m / Capital Employed (Equity 810.9m + L.T.Debt 140.0m))
RoIC = 21.64% (NOPAT 217.9m / Invested Capital 1.01b)
WACC = 8.30% (E(2.58b)/V(2.81b) * Re(8.97%) + D(229.9m)/V(2.81b) * Rd(1.00%) * (1-Tc(0.23)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.06%
[DCF Debug] Terminal Value 78.49% ; FCFE base≈118.3m ; Y1≈145.9m ; Y5≈249.0m
Fair Price DCF = 111.1 (DCF Value 3.56b / Shares Outstanding 32.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 46.31 | EPS CAGR: 121.3% | SUE: 0.38 | # QB: 0
Revenue Correlation: 84.92 | Revenue CAGR: 20.92% | SUE: -0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.14 | Chg30d=-0.178 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=4.84 | Chg30d=-0.834 | Revisions Net=-2 | Growth EPS=-5.4% | Growth Revenue=+0.9%
Additional Sources for IPAR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle